Featured

As large infrastructure funds siphon capital from early-stage climate-focused venture managers, more of the latter are turning to European LPs.

LPs are writing big checks for AI-focused funds managed by the industry’s largest players while turning away smaller players or funds that aren’t all-in with AI.

Growing familiarity with AI and machine learning is helping break down investors’ natural resistance to category-defying technologies.

Continuation vehicles allow VCs to hang on to a prized asset and deliver liquidity to their investors

The managing partner of Prysm Capital talks about his childhood in Seoul and why parenting has made him a better investor.

How a small accelerator born at the Francis Crick Institute is helping UK start-ups find investors who speak their language

A wearable sensor and machine learning are giving epilepsy patients weeks of seizure monitoring where days used to be the limit.

Bioconvergence products blur the lines between drugs, devices and software – and with them, the rules for getting to market.

The burgeoning space that mixes biology, engineering, computer science and AI has already delivered some big exits.

The reach of artificial intelligence now spans the entire drug pipeline, prompting Big Pharma to reconsider outsourcing innovation.